Cetera Investment Advisers
ANIX icon

Cetera Investment Advisers’s Anixa Biosciences ANIX Stock Holding History

Cetera Investment Advisers’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.7K Hold
11,127
– – ﹤0.01% 4632
2025
Q4 		$34.7K Buy
+11,127
New +$45.6K ﹤0.01% 4544

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cetera Investment Advisers's ANIX Position: Q1 2026 in Review

Cetera Investment Advisers held its Anixa Biosciences (ANIX) position steady in Q1 2026 at 11,127 shares worth $28.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4632.

Cetera Investment Advisers first reported a position in ANIX in Q4 2025 and has held it in 2 quarters since. The position peaked at $34.7K in Q4 2025. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Cetera Investment Advisers held 11,127 shares of Anixa Biosciences worth $28.7K as of Q1 2026.
  • Cetera Investment Advisers left its Anixa Biosciences share count unchanged in Q1 2026.
  • Anixa Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4632 holding.
  • Cetera Investment Advisers first reported a position in Anixa Biosciences in Q4 2025 and has held it in 2 quarters since.
  • Cetera Investment Advisers's Anixa Biosciences position peaked at $34.7K in Q4 2025.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.